Auto-injector

Information

  • Patent Grant
  • 11813436
  • Patent Number
    11,813,436
  • Date Filed
    Monday, May 8, 2023
    a year ago
  • Date Issued
    Tuesday, November 14, 2023
    6 months ago
Abstract
Auto-injector for administering a dose of a liquid medicament includes a housing to contain a syringe with a hollow needle and a stopper for sealing the syringe and displacing the medicament, the housing having a distal end and a proximal end with an orifice to apply against an injection site. A spring means, upon activation, can push the needle from inside the housing through the orifice and past the proximal end, operate the syringe to supply the dose of medicament, and retract the syringe with the needle after delivering the medicament. An activating means can lock the spring means in a pressurized state prior to manual operation and capable of, upon manual operation, releasing the spring means for injection.
Description
TECHNICAL FIELD

The invention relates to an auto-injector for administering a dose of a liquid medicament according to the preamble of claim 1.


BACKGROUND

Administering an injection is a process which presents a number of risks and challenges for users and healthcare professionals, both mental and physical.


Injection devices (i.e. devices capable of delivering medicaments from a medication container) typically fall into two categories—manual devices and auto-injectors.


In a manual device—the user must provide the mechanical energy to drive the fluid through the needle. This is typically done by some form of button/plunger that has to be continuously pressed by the user during the injection. There are numerous disadvantages to the user from this approach. If the user stops pressing the button/plunger then the injection will also stop. This means that the user can deliver an underdose if the device is not used properly (i.e. the plunger is not fully pressed to its end position). Injection forces may be too high for the user, in particular if the patient is elderly or has dexterity problems.


The extension of the button/plunger may be too great. Thus it can be inconvenient for the user to reach a fully extended button. The combination of injection force and button extension can cause trembling/shaking of the hand which in turn increases discomfort as the inserted needle moves.


Auto-injector devices aim to make self-administration of injected therapies easier for patients. Current therapies delivered by means of self-administered injections include drugs for diabetes (both insulin and newer GLP-1 class drugs), migraine, hormone therapies, anticoagulants etc.


Auto-injectors are devices which completely or partially replace activities involved in parenteral drug delivery from standard syringes. These activities may include removal of a protective syringe cap, insertion of a needle into a patient's skin, injection of the medicament, removal of the needle, shielding of the needle and preventing reuse of the device. This overcomes many of the disadvantages of manual devices. Injection forces/button extension, hand-shaking and the likelihood of delivering an incomplete dose are reduced. Triggering may be performed by numerous means, for example a trigger button or the action of the needle reaching its injection depth. In some devices the energy to deliver the fluid is provided by a spring.


US 2002/0095120 A1 discloses an automatic injection device which automatically injects a pre-measured quantity of fluid medicine when a tension spring is released. The tension spring moves an ampoule and the injection needle from a storage position to a deployed position when it is released. The content of the ampoule is thereafter expelled by the tension spring forcing a piston forward inside the ampoule. After the fluid medicine has been injected, torsion stored in the tension spring is released and the injection needle is automatically retracted back to its original storage position.


The spring means is a single compression spring arranged to be grounded at a distal end in the housing for advancing the needle and for injecting the dose of medicament via a plunger and wherein the compression spring is arranged to have its ground in the housing switched to its proximal end for retracting the syringe.


SUMMARY

It is an object of the present invention to provide an improved auto-injector.


The object is achieved by an auto-injector according to claim 1.


Preferred embodiments of the invention are given in the dependent claims.


In the context of this specification the term proximal refers to the direction pointing towards the patient during an injection while the term distal refers to the opposite direction pointing away from the patient.


According to the invention, an auto-injector for administering a dose of a liquid medicament comprises:

    • an elongate housing arranged to contain a syringe with a hollow needle and a stopper for sealing the syringe and displacing the medicament, the housing having a distal end and a proximal end with an orifice intended to be applied against an injection site, wherein the syringe is slidably arranged with respect to the housing,
    • spring means capable of, upon activation:
    • pushing the needle from a covered position inside the housing into an advanced position through the orifice and past the proximal end,
    • operating the syringe to supply the dose of medicament, and
    • retracting the syringe with the needle into the covered position after delivering the medicament,
    • activating means arranged to lock the spring means in a pressurized state prior to manual operation and capable of, upon manual operation, releasing the spring means for injection.


According to the invention the spring means is a single drive spring in the shape of a compression spring arranged to be grounded at a distal end in the housing for advancing the needle and for injecting the dose of medicament. The force of the drive spring is forwarded to the needle and/or the syringe via a plunger. The drive spring is arranged to have its ground in the housing switched to its proximal end for retracting the syringe when the injection of the medicament is at least nearly finished.


The single drive spring is used for inserting the needle, fully emptying the syringe and retracting the syringe and needle to a safe position after injection. Thus a second spring for withdrawing the syringe and needle, which is a motion with an opposite sense compared to advancing the syringe and injecting the dose, is not required. While the distal end of the drive spring is grounded the proximal end moves the syringe forward for inserting the needle and carries on to the injection by pushing on the stopper. When the injection is at least nearly finished the drive spring bottoms out at its proximal end, resulting in the proximal end being grounded in the housing. At the same time the distal end of the drive spring is released from its ground in the housing. The drive spring is now pulling the syringe in the opposite direction.


According to the invention the activating means is arranged as a trigger button laterally arranged on the housing. A lateral trigger button can be easier to operate for people with dexterity problems.


The auto-injector according to the invention has a particularly low part count compared to most conventional auto-injectors. The use of just one drive spring reduces the amount of metal needed and thus consequently reduces weight and manufacturing costs.


The trigger button is preferably pivoted in the housing and arranged to be rotated when operated.


An interlock sleeve may be telescoped in the proximal end of the housing, the interlock sleeve translatable in longitudinal direction between a proximal position and a distal position and biased in proximal direction in a manner to protrude from the housing in the proximal position. The interlock sleeve is arranged to be translated from its proximal position into an intermediate position when pressed against the injection site. The trigger button is arranged to push the interlock sleeve from the intermediate position into the distal position thus releasing the drive spring. Before the syringe and needle translate in proximal direction the activating means, i.e. the lateral trigger button has to be operated so as to release the drive spring. The probability for inadvertent operation of the auto-injector thus decreases due to the requirement of two user actions, pressing the auto-injector against the injection site and operating the trigger button.


In its proximal position the interlock sleeve may be arranged to hold the trigger button in a depressed position, e.g. flush with the housing. Translation of the interlock sleeve into the intermediate position causes the trigger button to emerge from the housing into a ready position. This provides a sequenced operation in a manner that the trigger button cannot be operated before the interlock sleeve is pressed against the injection site.


It is desirable to trigger the retraction of the needle when the contents of the syringe have been entirely delivered to the patient, i.e. when the stopper has bottomed out in the syringe. Automatically triggering the retraction when the stopper exactly reaches the end of its travel is a problem due to tolerances when manufacturing the syringe and stopper. Due to these tolerances the position of the stopper at the end of its travel relative to the retracting means is not repeatable. Consequently, in some cases the stopper would prematurely bottom out so the retraction would not be triggered at all. In other cases the retraction would be triggered before the stopper bottomed so residual medicament would remain in the syringe.


The retraction could automatically be triggered a certain amount of time or travel before the stopper bottoms out in the syringe. However this reliable retraction would be traded off for residual medicament in the syringe.


Thus, in a preferred embodiment the interlock sleeve is furthermore arranged to prevent release of the distal ground of the drive spring when in its intermediate and/or distal position. This means, the drive spring remains distally grounded as long as the auto-injector is kept pressed against the injection site so the needle retraction can only start when the auto-injector is removed from the injection site and the interlock sleeve consequently returns into its proximal position and thus releases the distal ground.


A retraction sleeve may be axially movable arranged in the housing, wherein the drive spring is arranged inside the retraction sleeve with its distal end bearing against a distal end face and with its proximal end bearing against a thrust face of a decoupling member. A resilient lug on the interlock sleeve is arranged to be engaged with the retraction sleeve by the trigger button being depressed when the interlock sleeve is in its intermediate or distal position so as to prevent the retraction sleeve from translating in distal direction. Thus, when the interlock sleeve is pressed against the injection site, the retraction sleeve is kept from retracting. Only after removal of the auto-injector from the injection site and consequent translation of the interlock sleeve into its proximal position the retraction sleeve may translate in distal direction and retract the needle into the housing.


The lug may be engaged between two ramps on the trigger button in such a manner that the trigger button is pulled into the depressed position upon translation of the interlock sleeve into its proximal position by the lug sliding along the first ramp. The trigger button is pushed into its ready position by the lug sliding along the second ramp.


A third ramp may be arranged on the interlock sleeve for being engaged by a pin on the trigger button when the trigger button is being pressed when the interlock sleeve is in its intermediate position. When the trigger button is being pressed the pin slides along the third ramp and translates the interlock sleeve into its distal position for triggering the injection.


A tubular syringe carrier may be arranged for holding the syringe and supporting it at its proximal end. Supporting the syringe at the proximal end is preferred over support at the finger flanges since the finger flanges are more frangible under load while the proximal or front end of the syringe is more robust. The syringe and the syringe carrier are arranged for joint axial translation. The syringe carrier is telescoped in the interlock sleeve.


In a preferred embodiment at least one latch is provided for axially fixing the retraction sleeve in a maximum proximal position. The decoupling member is arranged to decouple the latch when being moved in proximal direction nearly into a maximum proximal position. When decoupled, the retraction sleeve is allowed to move in distal direction and retract the needle by means of the spring force which is no longer grounded at its distal end. Thus, retraction can only occur if the latches have been released and if the auto-injector has been removed from the injection site.


Preferably the plunger is arranged for pushing the syringe and/or the stopper in proximal direction. At least one but preferably two or more resilient decoupling arms are arranged at the decoupling member. The decoupling arms exhibit inner ramped surfaces bearing against a first shoulder of the plunger in proximal direction. The resilient decoupling arms are supportable by an inner wall of the retraction sleeve in order to prevent the decoupling arms from being flexed outward and slip past the first shoulder. In this state the plunger may be pushed in proximal direction by the decoupling member pushing against the first shoulder in order to insert the needle and inject the dose. At least one aperture is arranged in the retraction sleeve allowing the decoupling arms to be flexed outward by the first shoulder thus allowing the first shoulder to slip through the decoupling arms in proximal direction. This may happen when the injection is at least nearly finished. The decoupled plunger allows the syringe and needle to be retracted since it is no longer bearing against the decoupling member.


The syringe may be arranged for joint axial movement with a syringe holder which is slidably arranged in the retraction sleeve. The syringe holder is provided with at least two resilient syringe holder arms arranged distally, the syringe holder arms having a respective inclined surface for bearing against a second shoulder, which is arranged at the plunger proximally from the first shoulder. The syringe holder arms are supportable by an inner surface of the housing in order to prevent them from being flexed outward. Thus, when the trigger button is pressed the spring force forwarded by the plunger does not yet press against the stopper but against the syringe for forwarding it. Consequently, a so called wet injection is avoided, i.e. the liquid medicament is not leaking out of the hollow needle before the needle is inserted. A widened portion is provided in the housing for allowing the syringe holder arms to flex outwards when the syringe holder has nearly reached a maximum proximal position thus allowing the second shoulder to slip through the syringe holder arms and to switch load of the drive spring from the syringe to the stopper. This allows for defining the moment to start injecting the medicament.


The syringe holder may have at least one stop for being engaged by a resilient first clip on the housing in a manner to prevent translation of the syringe holder in proximal direction. The first clip may be arranged to decouple from the stop upon translation of the interlock sleeve into its distal position in order to release the drive spring and start the injection.


Usually the hollow needle is equipped with a protective needle shield for keeping the needle sterile and preventing it from being mechanically damaged. The protective needle shield is attached to the needle when the auto-injector or the syringe is assembled.


Preferably a cap is provided at the proximal end of the housing. A sheet metal clip is attached to the cap for joint axial movement and independent rotation. The sheet metal clip is arranged to extend through an orifice into the interlock sleeve when the cap is attached to the interlock sleeve. The sheet metal clip incorporates at least two barbs snapped into a circumferential notch or behind a shoulder of the protective needle shield. This allows for automatically engaging the sheet metal clip with the protective needle shield during assembly. When the cap is removed from the interlock sleeve in preparation of an injection the protective needle shield is reliably removed without exposing the user too high a risk to injure themselves.


The cap may be attachable to the housing by a screw connection. This allows for a low force removal of the protective needle shield.


The housing may have at least one viewing window for inspecting the syringe.


The auto-injector may preferably be used for subcutaneous or intra-muscular injection, particularly for delivering one of an analgetic, an anticoagulant, insulin, an insulin derivate, heparin, Lovenox, a vaccine, a growth hormone, a peptide hormone, a proteine, antibodies and complex carbohydrates.


The cap with the sheet metal spring may also be applied with other auto-injectors and injection devices.


Further scope of applicability of the present invention will become apparent from the detailed description given hereinafter. However, it should be understood that the detailed description and specific examples, while indicating preferred embodiments of the invention, are given by way of illustration only, since various changes and modifications within the spirit and scope of the invention will become apparent to those skilled in the art from this detailed description.





BRIEF DESCRIPTION OF THE DRAWINGS

The present invention will become more fully understood from the detailed description given hereinbelow and the accompanying drawings which are given by way of illustration only, and thus, are not limitive of the present invention, and wherein:



FIGS. 1A-B are two longitudinal sections of an auto-injector with a single drive spring for advancing a syringe with a needle, injecting a dose of medicament and retracting the syringe and needle, the auto-injector as-delivered,



FIG. 2 is a longitudinal section of the auto-injector with a skin interlock sleeve translated in distal direction and a lateral trigger button ready to be operated, and



FIG. 3 is a detail of the auto-injector with the trigger button depressed.





Corresponding parts are marked with the same reference symbols in all figures.


DETAILED DESCRIPTION


FIGS. 1A-B show two longitudinal sections in different section planes of an auto-injector 1, the different section planes approximately 90° rotated to each other. The auto-injector 1 comprises an elongate housing 2. A syringe 3, e.g. a Hypak syringe, with a hollow needle 4 is arranged in a proximal part of the auto-injector 1. When the auto-injector 1 or the syringe 3 is assembled a protective needle shield may be attached to the needle (not illustrated). A stopper 6 is arranged for sealing the syringe 3 distally and for displacing a liquid medicament M through the hollow needle 4. The syringe 3 is held in a tubular syringe carrier 7 and supported at its proximal end therein. A single drive spring 8 in the shape of a compression spring is arranged in a distal part of the auto-injector 1. A plunger 9 is arranged for forwarding the spring force of the drive spring 8.


Inside the housing 2 a retraction sleeve 10 is slidably arranged. Before the injection is triggered the retraction sleeve 10 is in a maximum proximal position and prevented from moving in distal direction D by means of stops 11 caught behind latches 12 in the housing 2. A distal end of the drive spring 8 bears against an end face 13 of the retraction sleeve 10. Due to the stops 11 and latches 12 the force of the drive spring 8 is reacted into the housing 2. The proximal end of the drive spring 8 bears against a decoupling member 14 arranged around the plunger 9.


The decoupling member 14 comprises a thrust face 17 for bearing against a proximal end of the drive spring 8. Proximally from the thrust face 17 two or more resilient decoupling arms 18 are provided at the decoupling member 14, the decoupling arms 18 having inner ramped surfaces bearing against a first shoulder 19 in the plunger 9 in proximal direction P. The resilient decoupling arms 18 are supported by an inner wall of the retraction sleeve 10 in this situation so they cannot flex outward and slip past the first shoulder 19.


The syringe carrier 7 is engaged for joint axial movement with a syringe holder 22 which is slidably arranged in the retraction sleeve 10. The syringe holder 22 is provided with two or more resilient syringe holder arms 23 arranged distally. The syringe holder arms 23 have a respective inclined surface for bearing against a second shoulder 24 in the plunger 9 arranged proximally from the first shoulder 19. In the initial position shown in FIGS. 1A-B the syringe holder arms 23 are supported by an inner surface (not illustrated) of the housing 2 so they cannot flex outward and the second shoulder 24 cannot slip through. In order to support the syringe holder arms 23 at the housing 2 a respective number of apertures are provided in the retraction sleeve 10.


Two resilient first clips 2.1 are arranged in the housing 2 which engage stops 22.1 on the syringe holder 22 so as to prevent translation of the syringe holder 22, the syringe carrier 7, the syringe 3 and the needle 4 in proximal direction P. Since the syringe holder arms 23 are kept from flexing out, the load of the drive spring 8 is statically resolved through the decoupling member 14, the plunger 9 and the syringe holder 22 into the first clips 2.1 in the housing 2.


A lateral trigger button 20 is arranged laterally on the housing 2 with a pivot 20.1 near its proximal end. In the as delivered configuration in FIGS. 1A-B the trigger button 20 is flush with the housing 2 so it cannot be depressed.


A skin interlock sleeve 25 is telescoped in the proximal end P of the housing 2. An interlock spring 26 for biasing the interlock sleeve 25 in proximal direction P is arranged between the housing 2 and the interlock sleeve 25. The syringe carrier 7 is telescoped in a proximal portion 25.1 of the interlock sleeve 25. A distal portion 25.2 of the interlock sleeve 25 has a greater diameter than the proximal portion 25.1. The syringe holder 22 is telescoped in the distal portion 25.2. The distal portion 25.2 exhibits a lug 25.3 and a third ramp 25.4 for interacting with the trigger button 20. The lug 25.3 is caught between two ramps 20.2, 20.3 arranged inwardly in the trigger button 20.


In order to start an injection the proximal end P of the auto-injector 1 has to be pressed against the injection site, e.g. a patient's skin. As a result the interlock sleeve 25 translates in distal direction D into the housing 2 (see FIG. 2) until the interlock sleeve 25 is flush with the proximal end P of the housing 2. The lug 25.3 also moves in distal direction D along the second ramp 20.3 of the trigger button 20 thus rotating the trigger button outwardly in such a manner that the trigger button 20 laterally emerges from the housing 2 (see FIG. 2).


The trigger button 20 has now been moved to a position where if pushed it will release the drive spring 8 in order to insert the needle 4 into the injection site and to inject the medicament M.


If the auto-injector 1 is removed from the injection site without operating the trigger button 20 the interlock sleeve 25 will translate back into its proximal position under load of the interlock spring 26. The lug 25.3 will slide along the first ramp 20.2 and pull the trigger button 20 back into the position as in FIGS. 1A-B.


The lug 25.3 is resiliently arranged in the interlock sleeve 25 in such a manner that it may be pushed radially inwards. As long as the interlock sleeve 25 is in its proximal position as in FIGS. 1A-B the lug 25.3 is prevented from flexing inwards by the retraction sleeve 10. When the interlock sleeve 25 is pushed into the housing 2 as in FIG. 2 the lug 25.3 reaches an aperture 10.1 in the retraction sleeve 10 allowing it to flex inwards. If the interlock sleeve 25 is kept pressed against the injection site and the trigger button 20 is being depressed the lug 25.3 will be pushed inwards through the aperture 10.1. The resilience of the lug 25.3 has to be chosen so as to ensure that the force required to keep the interlock sleeve 25 pressed does not exceed a convenient level for the user since the counteracting force is the sum of the spring force of the interlock spring 26 and the force created by the lug 25.3 trying to slide along the second ramp 20.3.


When the lug 25.3 has entered the aperture 10.1 the skin interlock sleeve 25 is prevented from returning into its proximal position.


If the trigger button 20 was depressed with the interlock sleeve 25 only partially translated into the housing 2 the lug 25.3 would not yet have reached the aperture 10.1 so it could not flex inwards. Instead, depressing the trigger button 20 would force the interlock sleeve 25 back into its proximal position due to the engagement of the lug 25.3 with the second ramp 20.3.


When the trigger button 20 is pushed in the situation shown in FIG. 2, the lug 25.3 is pushed radially inwards. A pin 20.4, inwardly arranged on the trigger button 20, is pressed against the third ramp 25.4 in such a manner that the interlock sleeve 25 is translated further in distal direction D into the housing 2, as shown in FIG. 3. This movement will result in a further flexing of the lug 25.3, as it slides along the second ramp 20.3. This position cannot be reached by just pushing the interlock sleeve 25 against the injection site. A distal end of the distal portion 25.2 now reaches the clips 2.1 and pushes them outwards thus decoupling the syringe holder 22 from the housing 2 and releasing the drive spring 8.


The second shoulder 24 pushes the syringe holder 22, syringe carrier 7 and syringe 3 forward in proximal direction P while no load is exerted onto the stopper 6. The hollow needle 4 appears from the proximal end P and is inserted into the injection site.


The forward movement continues until the syringe holder 22 bottoms out at a front face 35 of the retraction sleeve 10. The travel from the initial position up to this point defines an injection depth, i.e. needle insertion depth.


When the syringe holder 22 has nearly bottomed out, the resilient syringe holder arms 23 have reached a widened portion 2.2 of the housing 2 where they are no longer supported by the inner wall of the housing 2. However, since the force required to insert the needle 4 is relatively low the second shoulder 24 will continue to drive forward the syringe holder 22 until proximal travel is halted at the front face 35. At this point the syringe holder arms 23 are flexed out by the continued force of the second shoulder 24 and allow it to slip through. Now the plunger 9 no longer pushes against the syringe holder 22 but against the stopper 6 for expelling the medicament M from the syringe 3 and injecting it into or through the patient's skin.


When the stopper 6 has nearly bottomed out in the syringe 3 the decoupling member 14 has reached a position where it pushes against the latches 12 in a manner to decouple the retraction sleeve 10 from the housing 2. Thus the drive spring 8 is no longer grounded with its distal end in the housing 2 by the latches 12. Instead, as soon as the decoupling member 14 has bottomed out at a second abutment 33 in the housing 2 the proximal end of the drive spring 8 gets grounded in the housing 2 while its distal end is pulling the retraction sleeve 10 in distal direction D.


Just before the decoupling member 14 decouples the retraction sleeve 10 from the housing 2 the decoupling arms 18 reach an aperture 10.1, 10.2 in the retraction sleeve 10 so they are no longer kept from being flexed outward. The decoupling arms 18 are thus pushed outward by the first shoulder 19 pushing against its ramped surfaces so the first shoulder 19 can slip through in distal direction D as soon as the decoupling member 14 has hit the second abutment 33.


Although the latches 12 are disengaged now, the retraction sleeve 10 may not yet slide in distal direction D because of the lug 25.3 engaged in the aperture 10.1 so the retraction sleeve 10 is trying to pull the interlock sleeve 25 in distal direction D which is prevented by the third ramp 25.4 distally abutting against the housing 2.


If the auto-injector 1 is taken away from the injection site and the user releases the trigger button 20 the lug 25.3 re-emerges from inside the retraction sleeve 10 so the retraction sleeve 10 gets disengaged from the interlock sleeve 25 and may now translate in distal direction D. A spring means may be arranged for actively pulling the trigger button 20 outwards in this situation. In an alternative embodiment the lug 25.3 may project outwards with an inclination in proximal direction P so as to allow the retraction sleeve 10 to push it outwards on retraction.


The syringe holder 22 is taken along in distal direction D by the retraction sleeve 10, e.g. by a front face 35. Thus the syringe 3 and needle 4 are retracted into a safe position inside the housing 2, e.g. into the initial position. The plunger 9, no longer bearing against the decoupling arms 18 is pulled back, too.


The housing 2 may have at least one viewing window for inspecting the syringe 3.


The auto-injector 1 may preferably be used for subcutaneous or intra-muscular injection, particularly for delivering one of an analgesic, an anticoagulant, insulin, an insulin derivate, heparin, Lovenox, a vaccine, a growth hormone, a peptide hormone, a protein, antibodies and complex carbohydrates.

Claims
  • 1. An auto-injector comprising: a housing having at least one viewing window for viewing a syringe disposed within the housing;a first part movably disposed relative to the housing and comprising a first surface and a second surface axially spaced apart from each other, the first part configured to move relative to the housing to initiate an injection of a medicament from the syringe;a second part slidably disposed relative to the first part and comprising a first proximally-extending resilient arm with an outward protrusion configured to engage the first surface of the first part such that movement of the first part causes movement of the second part,a first ramped portion configured to engage the second surface of the first part to cause inward deflection of the first proximally-extending resilient arm when the first ramped portion and the second surface move axially relative to each other, anda second portion configured to engage a second resilient arm of the auto-injector such that the second resilient arm outwardly deflects relative to the second part to release a plunger rod of the auto-injector from being held in a distal position within the housing such that the plunger rod moves proximally relative to the housing under a proximally-directed biasing force of a drive spring of the auto-injector to dispense the medicament from the syringe;a sleeve at least partially disposed within the second part and comprising an outer surface configured to engage an inner surface of a portion of the first proximally-extending resilient arm to prevent inward deflection of the first proximally-extending resilient arm from a relaxed position to a deflected position when the sleeve and the second part are in a first position relative to each other,an opening defined by the outer surface shaped and sized to receive the portion of the first proximally-extending resilient arm to allow inward deflection of the first proximally-extending resilient arm from the relaxed position to the deflected position and into the opening when the sleeve and the second part are in a second position relative to each other, the second part and the sleeve configured to move axially relative to each other from the first position to the second position, andan outward protrusion configured to couple the sleeve to the housing to limit axial movement of the sleeve relative to the housing, the outward protrusion being proximal of the opening; anda syringe carrier disposed within the housing and comprising a proximal portion configured to engage a proximal necked portion of the syringe to limit proximal movement of the syringe relative to the syringe carrier.
  • 2. The auto-injector of claim 1, wherein the auto-injector is configured such that distal movement of a proximal end of the auto-injector causes a needle sleeve spring to compress, the first part to move relative to the housing, and the second part to move relative to the housing.
  • 3. The auto-injector of claim 2, wherein the needle sleeve spring is disposed between the second part and the housing.
  • 4. The auto-injector of claim 3, wherein the proximal end of the auto-injector is configured to contact a body of a user and move distally relative to the housing when pressed against the body of the user.
  • 5. The auto-injector of claim 1, wherein an axial end of the sleeve is configured to be coupled to the syringe to bias the syringe in an axial direction.
  • 6. The auto-injector of claim 1, wherein a distal end of the syringe carrier comprises an outward portion configured to at least partially retain the syringe carrier within to the housing.
  • 7. The auto-injector of claim 6, wherein a distal end of the syringe comprises a distal flange that is distally spaced apart from the outward portion of the syringe carrier.
  • 8. The auto-injector of claim 1, comprising a third part comprising a third proximally-extending resilient arm configured to releasably engage a surface of the plunger rod to releasably couple proximal movement between the third part and the plunger rod as the plunger rod moves proximally relative to the housing to dispense the medicament from the syringe.
  • 9. The auto-injector of claim 8, wherein the third proximally-extending resilient arm is configured to releasably couple proximal movement between the third part and the plunger rod such that (i) the third part and the plunger rod proximally move together for a first distance as the plunger rod moves proximally relative to the housing to dispense the medicament from the syringe and (ii) the third part is decoupled from the plunger rod for a second distance as the plunger rod moves proximally relative to the housing to dispense the medicament from the syringe.
  • 10. An auto-injector comprising: a housing having at least one viewing window for viewing a syringe disposed within the housing;a first part movably disposed relative to the housing and comprising a first surface and a second surface axially spaced apart from each other;a second part slidably disposed relative to the first part and comprising a first proximally-extending resilient arm with an outward protrusion configured to engage the first surface of the first part such that movement of the first part causes movement of the second part,a first ramped portion configured to engage the second surface of the first part to cause inward deflection of the first proximally-extending resilient arm when the first ramped portion and the second surface move axially relative to each other, anda second portion configured to engage a second resilient arm of the auto-injector such that the second resilient arm outwardly deflects relative to the second part to release a plunger rod of the auto-injector from being held in a distal position within the housing such that the plunger rod moves proximally relative to the housing under a proximally-directed biasing force of a drive spring of the auto-injector to dispense the medicament from the syringe; anda sleeve at least partially disposed within the second part and configured to (i) prevent inward deflection of the first proximally-extending resilient arm when the sleeve and the second part are in a first position relative to each other and (ii) allow inward deflection of the first proximally-extending resilient arm when the sleeve and the second part are in a second position relative to each other, the second part and the sleeve configured to move axially relative to each other from the first position to the second position.
  • 11. The auto-injector of claim 10, comprising a syringe carrier disposed within the housing and comprising a proximal portion configured to engage a proximal necked portion of the syringe to limit proximal movement of the syringe relative to the syringe carrier, and an outward portion configured to at least partially retain the syringe carrier within to the housing.
  • 12. The auto-injector of claim 11, wherein a distal end of the syringe comprises a distal flange that is distally spaced apart from the outward portion of the syringe carrier and the syringe contains the medicament.
  • 13. The auto-injector of claim 10, wherein the auto-injector is configured such that distal movement of a proximal end of the auto-injector causes a needle sleeve spring to compress, the first part to move relative to the housing, and the second part to move relative to the housing, the needle sleeve spring being disposed between the second part and the housing.
  • 14. The auto-injector of claim 10, comprising a third part comprising a third proximally-extending resilient arm configured to releasably engage a surface of the plunger rod to releasably couple proximal movement between the third part and the plunger rod as the plunger rod moves proximally relative to the housing to dispense the medicament from the syringe.
  • 15. The auto-injector of claim 14, wherein the third proximally-extending resilient arm is configured to releasably couple proximal movement between the third part and the plunger rod such that (i) the third part and the plunger rod proximally move together for a first distance as the plunger rod moves proximally relative to the housing to dispense the medicament from the syringe and (ii) the third part is decoupled from the plunger rod for a second distance as the plunger rod moves proximally relative to the housing to dispense the medicament from the syringe.
  • 16. An auto-injector comprising: a housing having at least one viewing window for viewing a syringe disposed within the housing; anda first part movably disposed relative to the housing and comprising a first surface and a second surface axially spaced apart from each other;a second part slidably disposed relative to the first part and comprising a first proximally-extending resilient arm with an outward protrusion configured to engage the first surface of the first part such that movement of the first part causes movement of the second part,a first ramped portion configured to engage the second surface of the first part to cause inward deflection of the first proximally-extending resilient arm when the first ramped portion and the second surface move axially relative to each other, anda second portion configured to engage a second resilient arm of the auto-injector such that the second resilient arm outwardly deflects relative to the second part to release a plunger rod of the auto-injector from being held in a distal position within the housing such that the plunger rod moves proximally relative to the housing under a proximally-directed biasing force of a drive spring of the auto-injector to dispense the medicament from the syringe.
  • 17. The auto-injector of claim 16, comprising a syringe carrier disposed within the housing and comprising a proximal portion configured to engage a proximal necked portion of the syringe to limit proximal movement of the syringe relative to the syringe carrier.
  • 18. The auto-injector of claim 17, comprising a sleeve at least partially disposed within the second part and configured to (i) prevent inward deflection of the first proximally-extending resilient arm when the sleeve and the second part are in a first position relative to each other and (ii) allow inward deflection of the first proximally-extending resilient arm when the sleeve and the second part are in a second position relative to each other, the second part and the sleeve configured to move axially relative to each other from the first position to the second position.
  • 19. The auto-injector of claim 16, comprising a third part comprising a third proximally-extending resilient arm configured to releasably engage a surface of the plunger rod to releasably couple proximal movement between the third part and the plunger rod as the plunger rod moves proximally relative to the housing to dispense the medicament from the syringe.
  • 20. The auto-injector of claim 19, wherein the third proximally-extending resilient arm is configured to releasably couple proximal movement between the third part and the plunger rod such that (i) the third part and the plunger rod proximally move together for a first distance as the plunger rod moves proximally relative to the housing to dispense the medicament from the syringe and (ii) the third part is decoupled from the plunger rod for a second distance as the plunger rod moves proximally relative to the housing to dispense the medicament from the syringe.
  • 21. The auto-injector of claim 16, wherein the auto-injector is configured such that distal movement of a proximal end of the auto-injector causes a needle sleeve spring disposed between the second part and the housing to compress, the first part to move relative to the housing, and the second part to move relative to the housing.
  • 22. The auto-injector of claim 21, wherein the proximal end of the auto-injector is configured to contact a body of a user and move distally relative to the housing when pressed against the body of the user.
  • 23. A method comprising: moving a first part of an auto-injector and a sleeve of the auto-injector axially relative to each other to align an opening of the sleeve with a portion of a first proximally-extending resilient arm of the first part, an outward protrusion of the first proximally-extending resilient arm engaged to a first surface of a second part of the auto-injector such that movement of the second part causes movement of the first part while the first part and the sleeve are moved relative to each other to align the opening of the sleeve with the portion of the first proximally-extending resilient arm;moving the second part and the first part relative to each other while the opening is aligned with the portion of the first proximally-extending resilient arm such that a ramped portion of the first part engages with a second surface of the second part and the portion of the first proximally-extending resilient arm inwardly deflects into the opening of the sleeve, the first surface and the second surface being axially spaced apart from each other; andmoving the first part and the sleeve relative to each other to allow a second resilient arm of the auto-injector to outwardly deflect to release a plunger rod of the auto-injector from being held in a distal position within a housing of the auto-injector causing the plunger rod to proximally move relative to the housing, the sleeve, the first part, and the second part under a proximally-directed biasing force of a drive spring to dispense a medicament from a syringe disposed within the housing, a proximal necked portion of the syringe engaged to a proximal portion of a syringe carrier to limit proximal movement of the syringe relative to the syringe carrier, the housing having at least one viewing window for viewing the syringe.
  • 24. The method of claim 23, comprising engaging an inner surface of the portion of the first proximally-extending resilient arm with an outer surface of the sleeve to prevent inward deflection of the portion of the first proximally-extending resilient arm prior to aligning the opening with the portion of the first proximally-extending resilient arm.
  • 25. The method of claim 23, comprising inwardly deflecting the portion of the first proximally-extending resilient arm from a relaxed position in which the outward protrusion of the first proximally-extending resilient arm is engaged to the first surface of the second part to a deflected position in which the portion of the first proximally-extending resilient arm is received in the opening of the sleeve.
  • 26. The method of claim 23, comprising distally moving a proximal end of the auto-injector relative to the housing to release the plunger rod from being held in the distal position within the housing.
  • 27. The method of claim 26, wherein distally moving the proximal end of the auto-injector relative to the housing causes a needle sleeve spring of the auto-injector to compress, the first part to move relative to the housing, and the second part to move relative to the housing.
  • 28. The method of claim 23, comprising axially coupling an axial end of the sleeve to the syringe.
  • 29. The method of claim 23, comprising coupling an outward protrusion of the sleeve to the housing to limit axial movement of the sleeve relative to the housing.
  • 30. The method of claim 23, comprising engaging a third proximally-extending resilient arm of a third part of the auto-injector to the plunger rod to releasably couple axial movement between the third part and the plunger rod while the plunger rod moves relative to the housing to dispense the medicament from the syringe.
Priority Claims (1)
Number Date Country Kind
10167506 Jun 2010 EP regional
CROSS REFERENCE TO RELATED APPLICATIONS

The present application is a continuation of U.S. patent application Ser. No. 17/719,441, filed on Apr. 13, 2022, which is a continuation of U.S. patent application Ser. No. 16/809,669, filed on Mar. 5, 2020, now U.S. Pat. No. 11,311,671, which is a continuation of U.S. patent application Ser. No. 15/880,251, filed on Jan. 25, 2018, now U.S. Pat. No. 10,603,436, which is a continuation of U.S. patent application Ser. No. 15/165,720, filed on May 26, 2016, now U.S. Pat. No. 9,931,471, which is a continuation of U.S. patent application Ser. No. 13/806,324, filed on Dec. 21, 2012, now U.S. Pat. No. 9,352,088, which is a U.S. National Phase Application pursuant to 35 U.S.C. § 371 of International Application No. PCT/EP2011/060726, filed on Jun. 27, 2011, which claims priority to European Patent Application No. 10167506.4, filed on Jun. 28, 2010. The entire disclosure contents of these applications are herewith incorporated by reference into the present application.

US Referenced Citations (200)
Number Name Date Kind
5042977 Bechtold Aug 1991 A
5137516 Rand Aug 1992 A
5267963 Bachynsky Dec 1993 A
5320609 Haber Jun 1994 A
5681291 Galli Oct 1997 A
5746215 Brunnherg et al. May 1998 A
6004297 Steenfeldt-Jensen et al. Dec 1999 A
6159181 Crossman et al. Dec 2000 A
6221046 Burroughs Apr 2001 B1
6270479 Manjarrez Aug 2001 B1
6277099 Strowe et al. Aug 2001 B1
6454743 Weber Sep 2002 B1
6620137 Kirchhofer et al. Sep 2003 B2
7195616 Diller et al. Mar 2007 B2
7291132 DeRuntz et al. Nov 2007 B2
7297135 Jeffrey Nov 2007 B2
7341575 Rice et al. Mar 2008 B2
7361160 Hommann Apr 2008 B2
7407494 Bostrom et al. Aug 2008 B2
7442185 Amark et al. Oct 2008 B2
7597685 Olson Oct 2009 B2
7678085 Graf Mar 2010 B2
7717877 Lavi et al. May 2010 B2
7749195 Hommann Jul 2010 B2
7758550 Bollenbach et al. Jul 2010 B2
7771398 Knowles et al. Aug 2010 B2
7976494 Kohlbrenner et al. Jul 2011 B2
8038649 Kronestedt Oct 2011 B2
8048037 Kohlbrenner et al. Nov 2011 B2
8062255 Brunnberg et al. Nov 2011 B2
8083711 Enggaard Dec 2011 B2
8308695 Laiosa Nov 2012 B2
8323238 Cronenberg et al. Dec 2012 B2
8357125 Grunhut et al. Jan 2013 B2
8361025 Lawlis et al. Jan 2013 B2
8366680 Raab Feb 2013 B2
8376993 Cox et al. Feb 2013 B2
8376997 Hogdahl et al. Feb 2013 B2
8403883 Fayyaz et al. Mar 2013 B2
8409141 Johansen et al. Apr 2013 B2
8409148 Fiechter et al. Apr 2013 B2
8439864 Galbraith et al. May 2013 B2
8491538 Kohlbrenner et al. Jul 2013 B2
8568359 Carrel et al. Oct 2013 B2
8617109 Kronestedt et al. Dec 2013 B2
8617124 Wieselblad et al. Dec 2013 B2
8632507 Bartha Jan 2014 B2
8684969 Moller et al. Apr 2014 B2
8708973 Holmqvist Apr 2014 B2
8734402 Sharp et al. May 2014 B2
8758292 Tschirren et al. Jun 2014 B2
8808250 Ekman et al. Aug 2014 B2
8808251 Raab et al. Aug 2014 B2
8821451 Daniel Sep 2014 B2
8834431 Kohlbrenner et al. Sep 2014 B2
8840591 Raab et al. Sep 2014 B2
8882723 Smith et al. Nov 2014 B2
8911411 Nielsen Dec 2014 B2
8939934 Brereton et al. Jan 2015 B2
8945063 Wotton et al. Feb 2015 B2
8956331 Johansen et al. Feb 2015 B2
8961473 Heald Feb 2015 B2
8968256 Raab Mar 2015 B2
8968258 Nzike et al. Mar 2015 B2
8992484 Radmer et al. Mar 2015 B2
8992487 Eich et al. Mar 2015 B2
9005160 Karlsson et al. Apr 2015 B2
9011386 Kronestedt et al. Apr 2015 B2
9011387 Ekman et al. Apr 2015 B2
9022982 Karlsson et al. May 2015 B2
9022991 Moeller May 2015 B1
9022993 Dasbach et al. May 2015 B2
9022994 Moser et al. May 2015 B2
9044548 Miller et al. Jun 2015 B2
9044553 James et al. Jun 2015 B2
9057369 Kohlbrenner et al. Jun 2015 B2
9061104 Daniel Jun 2015 B2
9067024 Roberts et al. Jun 2015 B2
9072838 Hogdahl Jul 2015 B2
9089652 Nzike et al. Jul 2015 B2
9108002 Markussen Aug 2015 B2
9125988 Karlsson Sep 2015 B2
9132235 Holmqvist Sep 2015 B2
9132236 Karlsson et al. Sep 2015 B2
9155844 Brereton et al. Oct 2015 B2
9199038 Daniel Dec 2015 B2
9205199 Kemp et al. Dec 2015 B2
9233214 Kemp et al. Jan 2016 B2
9233215 Hourmand et al. Jan 2016 B2
9242044 Markussen Jan 2016 B2
9242047 Brereton et al. Jan 2016 B2
9272098 Hourmand et al. Mar 2016 B2
9283326 Kemp et al. Mar 2016 B2
9283327 Hourmand et al. Mar 2016 B2
9283328 Dasbach Mar 2016 B2
9308327 Marshall et al. Apr 2016 B2
9333304 Brereton et al. May 2016 B2
9339607 Langley et al. May 2016 B2
9352088 Ekman et al. May 2016 B2
9352090 Brereton May 2016 B2
9358345 Brereton et al. Jun 2016 B2
9358351 Ekman et al. Jun 2016 B2
9393368 Nzike et al. Jul 2016 B2
9408976 Olson et al. Aug 2016 B2
9408977 Butler et al. Aug 2016 B2
9408979 Veasey et al. Aug 2016 B2
9415165 Cowe Aug 2016 B2
9421336 Ekman et al. Aug 2016 B2
9427525 Barrow-Williams et al. Aug 2016 B2
9427527 Dasbach et al. Aug 2016 B2
9446195 Kramer et al. Sep 2016 B2
9446196 Hourmand et al. Sep 2016 B2
9446201 Holmqvist Sep 2016 B2
9457149 Kemp et al. Oct 2016 B2
9457152 Raab et al. Oct 2016 B2
9492622 Brereton et al. Nov 2016 B2
9707343 Fabien et al. Jul 2017 B2
9717851 Fabien et al. Aug 2017 B2
9895492 Fabien et al. Feb 2018 B2
9931471 Ekman et al. Apr 2018 B2
10420898 Daniel Sep 2019 B2
10500337 Fabien et al. Dec 2019 B2
10603436 Ekman et al. Mar 2020 B2
11311671 Ekman et al. Apr 2022 B2
20010005781 Bergens et al. Jun 2001 A1
20020007154 Hansen et al. Jan 2002 A1
20020095120 Larsen et al. Jul 2002 A1
20020123675 Trautman et al. Sep 2002 A1
20030105430 Lavi et al. Jun 2003 A1
20040039336 Amark et al. Feb 2004 A1
20050027255 Lavi et al. Feb 2005 A1
20050272551 Lavi et al. Feb 2005 A1
20050101919 Brunnberg May 2005 A1
20050222539 Gonzales et al. Oct 2005 A1
20060153693 Fiechter et al. Jul 2006 A1
20060287630 Hommann Dec 2006 A1
20070005021 Kohlbrenner et al. Jan 2007 A1
20070027430 Hommann Feb 2007 A1
20070112310 Lavi et al. May 2007 A1
20070197975 Burren et al. Aug 2007 A1
20080009807 Hommann Jan 2008 A1
20080015520 Hommann et al. Jan 2008 A1
20080051713 Kohlbrenner et al. Feb 2008 A1
20080228143 Stamp Sep 2008 A1
20080228147 David-Hegerich et al. Sep 2008 A1
20080262427 Hommann Oct 2008 A1
20080262438 Bollenbach et al. Oct 2008 A1
20080262443 Hommann Oct 2008 A1
20090012471 Harrison Jan 2009 A1
20090012479 Moller et al. Jan 2009 A1
20090270804 Mesa et al. Oct 2009 A1
20090312705 Grunhut et al. Dec 2009 A1
20100137798 Streit et al. Jun 2010 A1
20100137801 Streit et al. Jun 2010 A1
20100185178 Sharp et al. Jul 2010 A1
20100191217 Hommann Jul 2010 A1
20100268170 Carrel et al. Oct 2010 A1
20100286612 Cirillo et al. Nov 2010 A1
20100292653 Maritan Nov 2010 A1
20100298780 Laiosa Nov 2010 A1
20110077599 Wozencroft Mar 2011 A1
20110218500 Grunhut et al. Sep 2011 A1
20120010575 Jones et al. Jan 2012 A1
20120041387 Bruggemann et al. Feb 2012 A1
20120116319 Grunhut May 2012 A1
20120172817 Bruggemann et al. Jul 2012 A1
20120209192 Alexandersson Aug 2012 A1
20120310156 Karlsson et al. Dec 2012 A1
20130035647 Veasey et al. Feb 2013 A1
20130041328 Daniel Feb 2013 A1
20130123710 Ekman et al. May 2013 A1
20130261556 Jones et al. Oct 2013 A1
20130274662 Hourmand et al. Oct 2013 A1
20130274677 Ekman et al. Oct 2013 A1
20130281942 Teucher et al. Oct 2013 A1
20130289525 Kemp et al. Oct 2013 A1
20130310739 Galbraith et al. Nov 2013 A1
20130310744 Brereton et al. Nov 2013 A1
20130310745 Latham et al. Nov 2013 A1
20130310757 Brereton et al. Nov 2013 A1
20130317427 Brereton Nov 2013 A1
20130317428 Brereton et al. Nov 2013 A1
20130317479 Brereton Nov 2013 A1
20130324925 Brereton et al. Dec 2013 A1
20130324939 Brereton et al. Dec 2013 A1
20130345643 Hourmand et al. Dec 2013 A1
20140336590 Hourmand et al. Nov 2014 A1
20140343508 Hourmand et al. Nov 2014 A1
20150100029 Cowe et al. Apr 2015 A1
20150133872 Smith et al. May 2015 A1
20150273157 Kohlbrenner et al. Oct 2015 A1
20160051767 Higgins et al. Feb 2016 A1
20160058950 Marsh et al. Mar 2016 A1
20160067415 Bayer et al. Mar 2016 A1
20160067418 Morris et al. Mar 2016 A1
20160089498 Daniel Mar 2016 A1
20160144129 Mosebach et al. May 2016 A1
20160144133 Kemp May 2016 A1
20160151585 Kemp Jun 2016 A1
20180064875 Holmqvist Mar 2018 A1
Foreign Referenced Citations (100)
Number Date Country
705992 Jun 2013 CH
1901957 Jan 2007 CN
101264360 Mar 2008 CN
19819409 Nov 1999 DE
202007000578 Mar 2007 DE
102005052502 May 2007 DE
102007013836 Sep 2008 DE
0666084 Aug 1995 EP
0693946 Jan 1996 EP
0824923 Feb 1998 EP
0991441 Dec 2003 EP
1932558 Jun 2008 EP
2080532 Jul 2009 EP
2399634 Dec 2011 EP
2468334 Jun 2012 EP
2468335 Jun 2012 EP
2606924 Jun 2013 EP
2606925 Jun 2013 EP
2675502 Dec 2013 EP
2705861 Mar 2014 EP
2946801 Nov 2015 EP
2753381 Jan 2016 EP
2990865 Nov 2013 FR
2438592 Dec 2007 GB
2461088 Dec 2009 GB
2469672 Oct 2010 GB
H06-339737 Dec 1994 JP
2005-177503 Jul 2005 JP
2007-500530 Jan 2007 JP
2007-504867 Mar 2007 JP
2008-528144 Jul 2007 JP
2008-229344 Oct 2008 JP
2009-040604 Feb 2009 JP
2009-040607 Feb 2009 JP
2009-509605 Mar 2009 JP
2009-525059 Jul 2009 JP
WO 1996032974 Oct 1996 WO
WO 1999053979 Oct 1999 WO
WO 2000024441 May 2000 WO
WO 2000035060 Jun 2000 WO
WO 2002047746 Jun 2002 WO
WO 2003062672 Jul 2003 WO
WO 2004108194 Dec 2004 WO
WO 2005097238 Oct 2005 WO
WO 2006057604 Jun 2006 WO
WO 2007036676 Apr 2007 WO
WO 2007066152 Jun 2007 WO
WO 2007099044 Sep 2007 WO
WO 2007129324 Nov 2007 WO
WO 2008059385 May 2008 WO
WO 2008116688 Oct 2008 WO
WO 2009007305 Jan 2009 WO
WO 2009040604 Apr 2009 WO
WO 2009040607 Apr 2009 WO
WO 2009040672 Apr 2009 WO
WO 2009062508 May 2009 WO
WO 2009095701 Aug 2009 WO
WO 2010035059 Apr 2010 WO
WO 2010035060 Apr 2010 WO
WO 2010063707 Jun 2010 WO
WO 2011012903 Feb 2011 WO
WO 2011109205 Sep 2011 WO
WO 2011111006 Sep 2011 WO
WO 2011117592 Sep 2011 WO
WO 2011126439 Oct 2011 WO
WO 2012000939 Jan 2012 WO
WO 2012045350 Apr 2012 WO
WO 2012085024 Jun 2012 WO
WO 2012122643 Sep 2012 WO
WO 2013034647 Mar 2013 WO
WO 2013034651 Mar 2013 WO
WO 2013034984 Mar 2013 WO
WO 2013048310 Apr 2013 WO
WO 2013077800 May 2013 WO
WO 2013175139 Nov 2013 WO
WO 2013175144 Nov 2013 WO
WO 2013175148 Nov 2013 WO
WO 2013178512 Dec 2013 WO
WO 2014095424 Jun 2014 WO
WO 2014154491 Oct 2014 WO
WO 2015015170 Feb 2015 WO
WO 2015052224 Apr 2015 WO
WO 2015071123 May 2015 WO
WO 2015090320 Jun 2015 WO
WO 2015132234 Sep 2015 WO
WO 2015144870 Oct 2015 WO
WO 2015150578 Oct 2015 WO
WO 2015166286 Nov 2015 WO
WO 2015169608 Nov 2015 WO
WO 2015197866 Dec 2015 WO
WO 2016034407 Mar 2016 WO
WO 2016041883 Mar 2016 WO
WO 2016169718 Oct 2016 WO
WO 2016169719 Oct 2016 WO
WO 2016169756 Oct 2016 WO
WO 2016176785 Nov 2016 WO
WO 2016193350 Dec 2016 WO
WO 2016193622 Dec 2016 WO
WO 2016202555 Dec 2016 WO
WO 2021008839 Jan 2021 WO
Non-Patent Literature Citations (41)
Entry
International Preliminary Report on Patentability in Application No. PCT/EP2012/052647, dated Aug. 21, 2013, 8 pages.
International Preliminary Report on Patentability in Application No. PCT/EP2012/052648, dated Aug. 21, 2013, 6 pages.
International Preliminary Report on Patentability in International Application No. PCT/EP2011/060726, dated Dec. 28, 2012, 6 pages.
International Preliminary Report on Patentability in International No. PCT/EP2012/052642, dated Aug. 21, 2013, 7 pages.
International Search Report and Written Opinion in Application No. GB0906973.3, dated Aug. 26, 2009, 2 pages.
International Search Report and Written Opinion in Application No. PCT/EP2012/052639, dated May 11, 2012, 9 pages.
International Search Report and Written Opinion in Application No. PCT/EP2012/052640, dated May 14, 2012, 8 pages.
International Search Report and Written Opinion in Application No. PCT/EP2012/052646, dated Nov. 5, 2012, 9 pages.
International Search Report and Written Opinion in Application No. PCT/EP2012/052647, dated May 8, 2012, 10 pages.
International Search Report and Written Opinion in Application No. PCT/EP2012/052648, dated May 18, 2012, 8 pages.
International Search Report and Written Opinion in Application No. PCT/EP2012/059758, dated Aug. 13, 2012, 12 pages.
International Search Report and Written Opinion in Application No. PCT/EP2013/052653, dated May 11, 2012, 10 pages.
International Search Report and Written Opinion in International Application No. PCT/EP2011/060726, dated Aug. 31, 2011, 9 pages.
International Search Report and Written Opinion in International Application No. PCT/EP2012/052642, dated May 18, 2012, 11 pages.
International Search Report and Written Opinion in International Application No. PCT/EP2012/0526943, dated May 8, 2012, 10 pages.
International Search Report in Application No. PCT/EP2012/052643, dated Apr. 25, 2012, 3 pages.
International Search Report in Application No. PCT/EP2012/052652, dated May 10, 2012, 4 pages.
International Search Report in Application No. PCT/EP2012/052653, dated May 11, 2012, 3 pages.
International Search Report in Application No. PCT/SE99/01922, dated Mar. 28, 2000, 6 pages.
Japanese Office Action in Application No. 2013-517229, dated Jun. 9, 2015, 5 pages.
Japanese Office Action in Application No. 2013-553926, dated Jan. 5, 2016, 4 pages, English translation only.
Japanese Office Action in Application No. 2013-553927, dated Feb. 2, 2016, 5 pages.
Japanese Office Action in Application No. 2013-553931, dated Dec. 15, 2015, 5 pages, English translation only.
Japanese Office Action in Japanese Application No. 2013-553936, dated Dec. 22, 2015, 4 pages.
Merriam-Webster Dictionary , 2015 , Simple Definition, 1 page.
Office Action in U.S. Appl. No. 13/983,807, dated Dec. 24, 2015, 16 pages.
Office Action in U.S. Appl. No. 13/983,807, dated Jul. 28, 2015, 20 pages.
Office Action in U.S. Appl. No. 13/983,807, dated Oct. 21, 2016, 10 pages.
Office Action in U.S. Appl. No. 13/983,809, dated Mar. 28, 2016, 14 pages.
Office Action in U.S. Appl. No. 13/983,809, dated Sep. 27, 2016, 8 pages.
Office Action in U.S. Appl. No. 13/984,849, dated Jul. 26, 2016, 11 pages.
Office Action in U.S. Appl. No. 13/985,021, dated Jul. 26, 2016, 10 pages.
Office Action in U.S. Appl. No. 14/000,113, dated Mar. 19, 2015, 21 pages.
Russian Office Action in Application No. 2013/142343/14, dated Dec. 28, 2015, 6 pages, with English translation.
Russian Office Action in Application No. 2013/142356/14, dated Dec. 28, 2015, 6 pages, with English translation.
Russian Office Action in Application No. 2013/142356/14, dated Sep. 17, 2013, 6 pages.
Taiwan Search Report in Application No. 101105003, dated Nov. 5, 2015, 1 page.
Taiwan Search Report in Application No. 101105004, dated Nov. 3, 2015, 1 page.
Taiwan Search Report in Application No. 101105007, dated Oct. 22, 2015, 1 page.
Taiwan Search Report in Application No. 101105009, dated Oct. 31, 2015, 1 page.
Taiwan Search Report in Application No. 101105011, dated Oct. 31, 2015, 1 page.
Related Publications (1)
Number Date Country
20230270944 A1 Aug 2023 US
Continuations (5)
Number Date Country
Parent 17719441 Apr 2022 US
Child 18144555 US
Parent 16809669 Mar 2020 US
Child 17719441 US
Parent 15880251 Jan 2018 US
Child 16809669 US
Parent 15165720 May 2016 US
Child 15880251 US
Parent 13806324 US
Child 15165720 US